New analysis supports long-term treatment with Ofev® in SSc-ILD patients ...Middle East

RIDGEFIELD, Conn., Nov. 5, 2020 /PRNewswire/ -- Boehringer Ingelheim today announced results from an interim analysis of the SENSCIS®-ON trial evaluating Ofev® (nintedanib) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD). The new analysis was published...

Read More Details
Finally We wish PressBee provided you with enough information of ( New analysis supports long-term treatment with Ofev® in SSc-ILD patients )

Also on site :

• Help! My Wife and Her Siblings Just Took Ancestry DNA Tests. All Hell’s Broken Loose.
• Wall Street’s advice after Nvidia hits historic $4 trillion market cap: BUY
• Cheez-Its confirms huge recipe change – new crackers are missing a key ingredient from the original version